NCT00003414View on ClinicalTrials.gov

Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 1997

Primary Completion Date

May 31, 2004

Study Completion Date

May 31, 2004

Conditions
Graft Versus Host DiseaseLymphoma
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

recombinant interferon gamma

DRUG

busulfan

DRUG

cyclophosphamide

DRUG

cyclosporine

PROCEDURE

peripheral blood stem cell transplantation

RADIATION

radiation therapy

Trial Locations (1)

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00003414 - Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease | Biotech Hunter | Biotech Hunter